News

Get to know what's happening behind the scenes.

Learn more

Featured

Blog

Read the latest on our blog. Let's Talk Innovation.

Social

Stay connected with us on social media.

twitter_logo_20px.jpg @JNJinnovation

Events

Press Releases

Read our latest news.

  • Janssen Human Microbiome Institute Announces Multiple Collaborations to Accelerate the Translation of Microbiome Science into Health Solutions

    Cambridge, MA
    February 2, 2017

    Agreements with DayTwo, the Weizmann Institute of Science and Caelus Health Focus on Promoting Health through Microbiome Innovation

  • Caelus Health joins the JLINX Community

    Amsterdam, the Netherlands
    January 26, 2017

    Caelus Health has secured EUR 2.5 million in a Series A investment round, enabling the company to advance its pipeline of microbiota-based products for early intervention in cardio-metabolic disease.

    Caelus Health is one of the first companies fully dedicated to the clinical development of microbiota-based products for early intervention in cardio-metabolic disease. Caelus was founded in 2014 by prof. Max Nieuwdorp (Academic Medical Centre, AMC, Amsterdam) and prof. Willem M. De Vos (Wageningen University), based on the initial work with fecal transplant studies in the AMC. 

  • Verb Surgical Delivers Digital Surgery Prototype Demonstration to Collaboration Partners

Pages

Accelerators

Close
Neomed (Montreal)
7171 Frederick-Banting
Montreal, Quebec, CANADA H4S 1Z9
(514) 367 1212
mail@www.neomed.ca
www.neomed.ca
Your web browser is out of date. For the most optimal experience, please upgrade to the newest version of IE. Thank You.